Purebiox, Inc.

Falcon Heights, MN

UEI
XZAPQ4J49254
CAGE
8P6U9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2143 Folwell Ave, Falcon Heights, MN 55108, USA
Website
purebiox.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Frontline Biotechnologies Inc., doing business as Purebiox, is a corporate entity registered in SAM.gov since August 2020, located in St. Paul, Minnesota. The company is self-certified as a small disadvantaged business and operates as a for-profit organization focusing on developing advanced biotechnology solutions for water testing and pathogen detection. While specific details about the company's full background are limited, its federal grant award history indicates a strong emphasis on innovative microbiological and environmental detection technologies.

The company has received multiple federal grants from the National Science Foundation (NSF) and the Institute of Food Production and Sustainability, primarily focused on developing advanced water microbiological testing technologies and environmental DNA (eDNA) collection methods. Their most significant recent award is a $995,600 NSF Cooperative Agreement (Award ID: 2423051) to develop an end-to-end solution for high-volume water microbiological testing, specifically targeting early detection of waterborne viruses like SARS-CoV-2 and norovirus. Previous grants include a Phase I SBIR project (Award ID: 2224172) concentrating on nucleic acid collection and purification technologies for wastewater-based epidemiology, and two project grants related to sorbent technology for eDNA collection and concentration in aquaculture pathogen detection. These awards demonstrate Frontline Biotechnologies' commitment to developing innovative technologies that enhance public health monitoring, water safety, and pathogen detection across various environmental and healthcare applications.

Quick answers

Is Purebiox, Inc. registered in SAM.gov?

Yes. Purebiox, Inc.'s SAM.gov registration is active through April 5, 2027.

What is Purebiox, Inc.'s most recent federal award?

Purebiox, Inc.'s most recent federal grant award is Sbir phase II: development of an end-to-end solution for high-volume water microbiological testing (2423051), from National Science Foundation, on September 15, 2024.

On GovTribe

See Purebiox, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors